Probiotic supplementation studies, such as those by Böttcher and colleagues, showed that Lactobacillus reuteri reduces TGF-β2 levels in colostrum, lowering the risk of sensitization and IgE-associated eczema in infants [31]. Here, TGFB2 is linked to Eczematoid dermatitis.